Ballast Advisors »

Jazz Pharmaceuticals shares owned by Ballast Advisors

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Ballast Advisors from 13F filings

Historical chart of Ballast Advisors investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Ballast Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Ballast Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2k 22 189.05

More positions owned by Ballast Advisors

Schwab U.s. Large-cap Value Etf Etf (SCHV)
Schwab U.s. Large-cap Etf Etf (SCHX)
Schwab International Etf (SCHF)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
Ishares Core Us Etf (AGG)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Enterprise Products Partners (EPD)
Microsoft Corporation (MSFT)
Schwab Emerging Markets Equity Etf Etf (SCHE)
Taiwan Semiconductor Mfg (TSM)
Berkshire Hathaway (BRK.B)
NVIDIA Corporation (NVDA)
Schwab U.s. Small-cap Etf Etf (SCHA)
Uber Technologies (UBER)

View all positions for Ballast Advisors

Top funds holding Jazz Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Capital World Investors
Vanguard Capital Management
LSV Asset Management
FMR
Franklin Resources
Dimensional Fund Advisors
State Street Corporation
EcoR1 Capital
Bank of New York Mellon
Hanna Zanoni
Ameriprise Financial
Citadel Advisors
AQR Capital Management

View all funds holding Jazz Pharmaceuticals